Citations for
1AKR1B10
AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
Schmitz KJ, Sotiropoulos GC, Baba HA, Schmid KW, Müller D, Paul A, Auer T, Gamerith G, Loeffler-Ragg J.
Liver Int 31(6):810-6. doi: 10.1111/j.1478-3231.2011.02511.x. Epub 2011 Mar 29. 2011
2AKR1B10
Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway.
Luo DX, Huang MC, Ma J, Gao Z, Liao DF, Cao D.
Biochem J 438(1):71-80. 2011
3AKR1B10, NFE2L2
Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity.
Díez-Dacal B, Gayarre J, Gharbi S, Timms JF, Coderch C, Gago F, Pérez-Sala D.
Cancer Res 71(12):4161-71. Epub 2011 Apr 20. 2011
4AKR1B10
Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, Tannapfel A.
J Hepatol 52(2):220-7. Epub 2009 Nov 25. 2010
5AKR1B10
Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.
Liu Z, Zhong L, Krishack PA, Robbins S, Cao JX, Zhao Y, Chung S, Cao D.
Gene 437(1-2):39-44. Epub 2009 Feb 21. 2009
6AKR1B10
Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10.
Quinn AM, Harvey RG, Penning TM.
Chem Res Toxicol 21(11):2207-15. 2008
7AKR1B10
Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma.
Breton J, Gage MC, Hay AW, Keen JN, Wild CP, Donnellan C, Findlay JB, Hardie LJ.
J Proteome Res 7(5):1953-62. Epub 2008 Apr 9. 2008
8AKR1B10
AKR1B10 in usual interstitial pneumonia: expression in squamous metaplasia in association with smoking and lung cancer.
Li CP, Goto A, Watanabe A, Murata K, Ota S, Niki T, Aburatani H, Fukayama M.
Pathol Res Pract 204(5):295-304. Epub 2008 Mar 20. 2008
9AKR1B10
Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
Ma J, Yan R, Zu X, Cheng JM, Rao K, Liao DF, Cao D.
J Biol Chem 283(6):3418-23. Epub 2007 Dec 1. 2008
10AKR1B10
Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
Yan R, Zu X, Ma J, Liu Z, Adeyanju M, Cao D.
Int J Cancer 121(10):2301-6. 2007
11AKR1B10
Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas.
Zeindl-Eberhart E, Haraida S, Liebmann S, Jungblut PR, Lamer S, Mayer D, Jager G, Chung S, Rabes HM.
Hepatology 39(2):540-9. 2004
12AKR1B1P1, AKR1B10
Identification and characterization of a novel human aldose reductase-like gene.
Cao D, et al.
J Biol Chem 273 : 11429-11435. 1998
13AKR1B10
Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family.
Hyndman DJ, Flynn TG.
Biochim Biophys Acta 1399(2-3):198-202. 1998